Suppr超能文献

再移植肝脏的新基准值:结果是否合理?

Novel Benchmark Values for Redo Liver Transplantation: Does the Outcome Justify the Effort?

机构信息

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

Department of General, Abdominal and Transplant Surgery, Croix-Rousse Hospital, Lyon, France.

出版信息

Ann Surg. 2022 Nov 1;276(5):860-867. doi: 10.1097/SLA.0000000000005634. Epub 2022 Jul 27.

Abstract

OBJECTIVE

To define benchmark cutoffs for redo liver transplantation (redo-LT).

BACKGROUND

In the era of organ shortage, redo-LT is frequently discussed in terms of expected poor outcome and wasteful resources. However, there is a lack of benchmark data to reliably evaluate outcomes after redo-LT.

METHODS

We collected data on redo-LT between January 2010 and December 2018 from 22 high-volume transplant centers. Benchmark cases were defined as recipients with model of end stage liver disease (MELD) score ≤25, absence of portal vein thrombosis, no mechanical ventilation at the time of surgery, receiving a graft from a donor after brain death. Also, high-urgent priority and early redo-LT including those for primary nonfunction (PNF) or hepatic artery thrombosis were excluded. Benchmark cutoffs were derived from the 75th percentile of the medians of all benchmark centers.

RESULTS

Of 1110 redo-LT, 373 (34%) cases qualified as benchmark cases. Among these cases, the rate of postoperative complications until discharge was 76%, and increased up to 87% at 1-year, respectively. One-year overall survival rate was excellent with 90%. Benchmark cutoffs included Comprehensive Complication Index CCI ® at 1-year of ≤72, and in-hospital and 1-year mortality rates of ≤13% and ≤15%, respectively. In contrast, patients who received a redo-LT for PNF showed worse outcomes with some values dramatically outside the redo-LT benchmarks.

CONCLUSION

This study shows that redo-LT achieves good outcome when looking at benchmark scenarios. However, this figure changes in high-risk redo-LT, as for example in PNF. This analysis objectifies for the first-time results and efforts for redo-LT and can serve as a basis for discussion about the use of scarce resources.

摘要

目的

定义再次肝移植(redo-LT)的基准截止值。

背景

在器官短缺的时代,再次肝移植经常被讨论,认为其预后不良且浪费资源。然而,缺乏可靠评估再次肝移植后结果的基准数据。

方法

我们从 22 个高容量移植中心收集了 2010 年 1 月至 2018 年 12 月期间进行的再次肝移植的数据。基准病例定义为终末期肝病模型(MELD)评分≤25、无门静脉血栓形成、手术时无机械通气、接受脑死亡供体的移植物的受者。此外,排除了高紧急优先级和早期再次肝移植,包括原发性无功能(PNF)或肝动脉血栓形成。基准截止值是从所有基准中心中位数的第 75 个百分位数推导出来的。

结果

在 1110 例再次肝移植中,373 例(34%)符合基准病例标准。在这些病例中,术后并发症直至出院的发生率为 76%,分别在 1 年时增加至 87%。1 年总生存率非常高,为 90%。基准截止值包括 1 年时综合并发症指数 CCI ® ≤72,住院和 1 年死亡率分别为≤13%和≤15%。相比之下,接受 PNF 再次肝移植的患者预后较差,某些数值明显超出再次肝移植的基准。

结论

本研究表明,在考虑基准情况时,再次肝移植可获得良好的结果。然而,在高危再次肝移植中,例如 PNF,情况会发生变化。这种分析首次客观地评估了再次肝移植的结果和努力,可以为讨论稀缺资源的使用提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92e5/9983740/cbaa73b1f447/sla-276-860-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验